Total reported value
$4.0B
Reporting period: 2026-03-31 · Number of holdings: 27
Alphabet Inc. disclosed 27 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $4.0B and a quarterly turnover rate of 61.0%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "A"
Trim ASTS
0.0% $91.6M
Trim FRSH
0.0% -$68.4M
Trim PATH
0.0% -$37.2M
Trim GTLB
0.0% -$43.3M
Trim RVMD
-1.6% $53.8M
Trim TEM
0.0% -$21.5M
Showing top 26 holdings (of 27 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CME | Cme Group INC | Stock-Financials | 25.63% | +25.63% | NEW | |
| 2 | PL | Planet Labs Pbc | Stock-Industrials | 24.53% | +0.11% | +10.35% | |
| 3 | ASTS | Ast Spacemobile INC | Stock-Tech | 18.46% | -6.72% | — | |
| 4 | RVMD | Revolution Medicines INC | Stock-Healthcare | 7.97% | -2.36% | -1.57% | |
| 5 | ARM | Arm Holdings Plc-adr | Stock-Tech | 7.39% | -0.92% | — | |
| 6 | FRSH | Freshworks Inc-cl A | Stock-Other | 3.24% | -4.46% | — | |
| 7 | PATH | Uipath INC - Class A | Stock-Tech | 1.94% | -2.53% | — | |
| 8 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 1.75% | -1.80% | — | |
| 9 | PAYP | Paypay CORP | Stock-Other | 1.66% | +1.66% | NEW | |
| 10 | GTLB | Gitlab Inc-cl A | Stock-Tech | 1.47% | -2.49% | — | |
| 11 | PRME | Prime Medicine INC | Stock-Other | 1.44% | -0.79% | — | |
| 12 | LIFE | Ethos Technologies INC Cl-a | Stock-Other | 1.05% | +1.05% | NEW | |
| 13 | MAZE | Maze Therapeutics INC | Stock-Other | 1.03% | -1.20% | — | |
| 14 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 0.63% | -0.74% | — | |
| 15 | RLAY | Relay Therapeutics INC | Stock-Other | 0.39% | -0.12% | -0.29% | |
| 16 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 0.28% | -0.17% | -8.14% | |
| 17 | VERA | Vera Therapeutics INC | Stock-Other | 0.24% | -0.23% | — | |
| 18 | SANA | Sana Biotechnology INC | Stock-Other | 0.20% | -0.24% | — | |
| 19 | BEAM | Beam Therapeutics INC | Stock-Other | 0.19% | -0.16% | — | |
| 20 | LYEL | Lyell Immunopharma INC | Stock-Other | 0.15% | -0.20% | — | |
| 21 | OSCR | Oscar Health INC - Class A | Stock-Healthcare | 0.14% | -0.13% | — | |
| 22 | FIG | Figma Inc-cl A | Stock-Other | 0.11% | -0.20% | — | |
| 23 | SPRO | Spero Therapeutics INC | Stock-Other | 0.05% | -0.03% | — | |
| 24 | HYPR | Hyperfine INC | Stock-Other | 0.02% | -0.01% | — | |
| 25 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.02% | -0.03% | — | |
| 26 | TNYA | Tenaya Therapeutics INC | Stock-Other | 0.02% | -0.01% | — |
Performance for Q3 2026
-4.9%
Performance Last 4 Quarters
+86.4%
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 27 | $4.0B | 61 | |
| 2025-12-31 | 32 | $2.6B | 37 | |
| 2025-09-30 | 40 | $2.4B | 49 | |
| 2025-06-30 | 39 | $2.1B | 0 | |
| 2025-03-31 | 44 | $1.6B | 0 | |
| 2024-12-31 | 44 | $1.7B | 0 | |
| 2024-09-30 | 46 | $1.8B | 0 | |
| 2024-06-30 | 46 | $2.0B | 0 | |
| 2024-03-31 | 47 | $2.5B | 0 | |
| 2023-12-31 | 48 | $2.2B | 0 | |
| 2023-09-30 | 51 | $1.6B | 0 | |
| 2023-06-30 | 56 | $1.9B | 0 | |
| 2023-03-31 | 58 | $1.8B | 0 | |
| 2022-12-31 | 61 | $1.7B | 0 | |
| 2022-09-30 | 59 | $2.0B | 0 | |
| 2022-06-30 | 65 | $1.8B | 0 | |
| 2022-03-31 | 70 | $3.1B | 0 | |
| 2021-12-31 | 67 | $4.1B | 0 | |
| 2021-09-30 | 52 | $4.2B | 0 | |
| 2021-06-30 | 44 | $4.9B | — | |
| 2021-03-31 | 37 | $2.5B | — | |
| 2020-12-31 | 33 | $2.1B | — | |
| 2020-09-30 | 26 | $2.1B | — | |
| 2020-06-30 | 26 | $2.2B | — | |
| 2020-03-31 | 28 | $1.5B | — | |
| 2019-12-31 | 27 | $1.7B | — | |
| 2019-09-30 | 27 | $3.3B | — | |
| 2019-06-30 | 26 | $5.3B | — | |
| 2019-03-31 | 19 | $1.9B | — | |
| 2018-12-31 | 18 | $845.8M | — | |
| 2018-09-30 | 17 | $1.0B | — | |
| 2018-06-30 | 17 | $1.2B | — | |
| 2018-03-31 | 11 | $614.8M | — | |
| 2017-12-31 | 8 | $368.6M | — | |
| 2017-09-30 | 4 | $344.0M | — | |
| 2017-06-30 | 4 | $347.4M | — | |
| 2017-03-31 | 3 | $316.8M | — | |
| 2016-12-31 | 2 | $292.8M | — | 1G0551A2TWTRUSD |
| 2016-09-30 | 2 | $275.2M | — | 1G0551A2LCEUR |
| 2016-06-30 | 3 | $209.8M | — | |
| 2016-03-31 | 5 | $242.9M | — | |
| 2015-12-31 | 6 | $326.8M | — | |
| 2015-09-30 | 7 | $416.1M | — | |
| 2015-06-30 | 7 | $482.2M | — | |
| 2015-03-31 | 6 | $601.0M | — | |
| 2014-12-31 | 7 | $659.6M | — | |
| 2014-09-30 | 4 | $304.5M | — | |
| 2014-06-30 | 4 | $383.2M | — | |
| 2014-03-31 | 3 | $381.2M | — | |
| 2013-12-31 | 4 | $365.1M | — | 104270V2350465376132B |
Alphabet Inc.'s most significant position changes for 2026-03-31: New buy: Cme Group INC (CME); Sold out: Dexcom INC (DXCM); New buy: Paypay CORP (PAYP); New buy: Ethos Technologies INC Cl-a (LIFE); Sold out: Genedx Holdings CORP (WGS).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PL | Planet Labs Pbc | +0.1% | +10.35% | Add |
| 2 | HYPR | Hyperfine INC | 0% | — | Unchanged |
| 3 | TNYA | Tenaya Therapeutics INC | 0% | — | Unchanged |
| 4 | AUTL | Autolus Therapeutics PLC | 0% | — | Unchanged |
| 5 | SPRO | Spero Therapeutics INC | 0% | — | Unchanged |
| 6 | RLAY | Relay Therapeutics INC | -0.1% | -0.29% | Trim |
| 7 | OSCR | Oscar Health INC - Class A | -0.1% | — | Unchanged |
| 8 | BEAM | Beam Therapeutics INC | -0.2% | — | Unchanged |
| 9 | GLUE | Monte Rosa Therapeutics INC | -0.2% | -8.14% | Trim |
| 10 | FIG | Figma Inc-cl A | -0.2% | — | Unchanged |
| 11 | LYEL | Lyell Immunopharma INC | -0.2% | — | Unchanged |
| 12 | VERA | Vera Therapeutics INC | -0.2% | — | Unchanged |
| 13 | SANA | Sana Biotechnology INC | -0.2% | — | Unchanged |
| 14 | BBOT | Bridgebio Oncology Therapeut | -0.7% | — | Unchanged |
| 15 | PRME | Prime Medicine INC | -0.8% | — | Unchanged |
| 16 | ARM | Arm Holdings Plc-adr | -0.9% | — | Unchanged |
| 17 | MAZE | Maze Therapeutics INC | -1.2% | — | Unchanged |
| 18 | TEM | Tempus Ai Inc-cl A | -1.8% | — | Unchanged |
| 19 | RVMD | Revolution Medicines INC | -2.4% | -1.57% | Trim |
| 20 | GTLB | Gitlab Inc-cl A | -2.5% | — | Unchanged |
| 21 | PATH | Uipath INC - Class A | -2.5% | — | Unchanged |
| 22 | FRSH | Freshworks Inc-cl A | -4.5% | — | Unchanged |
| 23 | ASTS | Ast Spacemobile INC | -6.7% | — | Unchanged |
| 24 | CME | Cme Group INC | — | NEW | New buy |
| 25 | DXCM | Dexcom INC | — | EXIT | Sold out |
| 26 | PAYP | Paypay CORP | — | NEW | New buy |
| 27 | LIFE | Ethos Technologies INC Cl-a | — | NEW | New buy |
| 28 | WGS | Genedx Holdings CORP | — | EXIT | Sold out |
| 29 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 30 | QNCX | Quince Therapeutics, Inc. | — | EXIT | Sold out |
| 31 | FULC | Fulcrum Therapeutics INC | — | EXIT | Sold out |
| 32 | RGEN | Repligen CORP | — | EXIT | Sold out |
Institutions with a similar AUM
CIK 0002105395
Total reported value
$4.0B
169 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001909316
Total reported value
$4.0B
3,980 stks
2026-03-31
AUM within 0.3% of this institution
CIK 0001475045
Total reported value
$4.0B
1,357 stks
2026-03-31
AUM within 0.5% of this institution
Institutions with overlapping top holdings
CIK 0000020286
Total reported value
$5.0B
55 stks
2026-03-31
1 of the top 5 holdings overlap, including Cme Group INC
CIK 0000313807
Total reported value
$17.7M
1 stks
2026-03-31
1 of the top 5 holdings overlap, including Cme Group INC
CIK 0000852743
Total reported value
$3.0B
5 stks
2026-03-31
1 of the top 5 holdings overlap, including Cme Group INC